Byju Fiasco: A Blow To Start-Up Ecosystem
Indian Economy & Market|July 2023
Byju's, which arose as perhaps one of the most dominant start-ups after Flipkart, is on a slippery slope. Issues like defaulting on loan settlement, handing over pink slips to thousands of employees, delayed release of FY22 financial statements, the resignation of the auditor, and, the exit of three external board members without giving specific reasons raise serious questions vis-à-vis corporate governance. And it does not augur well for the start-up ecosystem, which has thrived on easy money flowing in from foreign investors. Pathetic governance and scam will put off financiers making it all the more difficult for the honest ones to raise money.
Shivanand Pandit
Byju Fiasco: A Blow To Start-Up Ecosystem

IF the pandemic years had spawned hopefulness for domestic start-ups to make a mark in India, the year 2023 is turning out to be nightmarish for them. Byju's, the most well-liked, homegrown Ed Tech titan, recognized as the flag possessor of India's start-up ecosystem, has run into rough weather. Its action of handing over pink slips to thousands of employees and the exit of external board members did not augur well for the start-up environment. The resignation of the auditor was the final nail in the coffin.

There is a picture being painted by a few industry experts that the whole entity may be sold off to an old-fashioned firm that is considering moving into the education or Edutech business. That raises the vital question: how did Byju's get into this kind of trouble?

It would be comfortable to give an easy answer the problems originate from Byju Raveendran's misadministration of the company, his plentiful unhealthy acquisitions, floppy financial controls, a noxious work philosophy, and other such matter. The hostile tactic for quick development through inorganic direction by acquiring over and above 17 companies across geographies and its failure to stick to accounting and ethical standards in pursuit of expansion should have led to the present sordid state of affairs. Byju's would have gotten into a dilemma sooner or later because of these matters and, the funding winter in start-ups only triggered the crisis. Byju Raveendran's management is no doubt the main cause behind the company's troubles. But the very fact that he could get into this big a mess before things blew up despite warning signals being available for quite some time is a good example of the way Venture Capitalists (VCS) have slanted the start-up playing field.

Why Do Many Start-Ups Fail?

この記事は Indian Economy & Market の July 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Indian Economy & Market の July 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

INDIAN ECONOMY & MARKETのその他の記事すべて表示
Globalism, Freedom & Democracy Do Not Mix
Indian Economy & Market

Globalism, Freedom & Democracy Do Not Mix

The world today is packed with wealthy institutions and individuals that stand in revolt against the ideas of freedom and democracy. They do not like the idea of geographically constrained states with zones of juridical power.

time-read
6 分  |
November 2024
WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP
Indian Economy & Market

WORLD DEVELOPMENT REPORT 2024 THE MIDDLE-INCOME TRAP

A World Bank report titled 'World Development Report 2024: The Middle-Income Trap' indicates that India may take up to 75 years to attain just a quarter of the United States' per capita income. The insights in the report provides a useful reality check for India's ambitious goals, such as becoming a developed economy by 2047 or reaching a $5 trillion economy within the next three years.

time-read
5 分  |
November 2024
IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”
Indian Economy & Market

IN CONVERSATION: "We are working with a Vision 2035. I'm sure within next 5 years we will be ranking among the Fortune 500 companies.”

Sudarshan Pharma Industries Ltd., led by its promoters, Mr. Hemal V. Mehta, a chemical engineer, and Mr. Sachin V. Mehta, has established a strong foundation in specialty chemicals and bulk drugs. Their relentless enthusiasm is visible when they speak. Indian Economy & Market reached out, to piece together the company's achievements and new initiatives in detail.

time-read
9 分  |
November 2024
Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING
Indian Economy & Market

Sudarshan Pharma Industries Ltd. A MULTIBAGGER IN MAKING

Sudarshan Pharma Industries Ltd. operates across various sectors in both the pharmaceutical and chemical industries, with a focus on specialty chemicals and intermediates, which find applications in Indian Le pharmaceuticals, paints, food products, and adhesives.

time-read
3 分  |
November 2024
MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS
Indian Economy & Market

MUTUAL FUND LITE OR MF LIT PROMISING PROGRESS FOR INVESTORS

The SEBI has streamlined rules for passively managed schemes to have the impact of letting more players in the mutual fund ecosystem and offering diversified, low-risk investment options to retail investors. It would increase market liquidity and attract participation from old as well as new Asset Management Companies (AMCs). Shivanand Pandit feels that MF Lite is going to democratize investment opportunities in the Indian financial market.

time-read
5 分  |
November 2024
BRICS Member States Ready to Dethrone Dollar
Indian Economy & Market

BRICS Member States Ready to Dethrone Dollar

AS the US weaponises the dollar in the Russian and Iranian sanctions, there is increasing desire by other developing countries to seek alternative currencies for trade, investment, and reserves, as well as developing alternative multilateral clearance systems outside of SWIFT.

time-read
3 分  |
November 2024
7 BEST PHARMA COMPANIES
Indian Economy & Market

7 BEST PHARMA COMPANIES

The pharmaceutical industry in India is expected to reach $65 Bn by end of 2024 and to $130 Bn by 2030. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. While Nifty's performance has been lackluster over the past month, several pharmaceutical stocks have shown resilience.

time-read
10+ 分  |
November 2024
NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?
Indian Economy & Market

NEW INVESTMENT PRODUCT CATEGORY IS SEBI'S LATEST MOVE COMMENDABLE?

The Securities and Exchange Board of India (SEBI) has introduced a consultation paper proposing a new investment product category aimed at addressing a specific market need. This proposed asset class would offer investment options that sit between mutual funds (MFS) and PMS, filling a gap and providing greater flexibility in portfolio management. The new investment vehicle is designed for investors who are prepared to take on riskier market positions but find PMS schemes or AIFs out of reach. SEBI after reviewing the feedback and finalizing the regulations through stakeholder discussions, may issue the final regulations.

time-read
5 分  |
August 2024
DECODING THE CHINA MYTH
Indian Economy & Market

DECODING THE CHINA MYTH

Myths die hard. Among these is the great myth that China's poised to take over the world. Here, James Rickards debunks that myth.

time-read
7 分  |
August 2024
What Is In Store For The Indian Economy?
Indian Economy & Market

What Is In Store For The Indian Economy?

Until the 2014 Lok Sabha elections, when the Bharatiya Janata Party secured 282 seats and Narendra Modi ascended to power, India experienced 21 years of coalition governments. A decade later, the BJP holds 240 seats in the Lok Sabha, and India is once again governed by a coalition. Fitch has indicated that coalition politics and a weakened mandate for the NDA could hinder the passage of ambitious reform legislation. It raises the question: Do coalition governments impede the economic reform agenda?

time-read
5 分  |
July 2024